Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Nephrology|January 1, 1981
Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trialS Kiilerich, C Christiansen, M S Christensen, et al.
Clinical Endocrinology|September 1, 1981
A possible direct effect of 24,25-dihydroxycholecalciferol on the parathyroid gland in patients with chronic renal failureC Christiansen, P Rødbro, J Naestoft, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1975
Dose-dependent kinetics of ethotoin in manSjö, E F Hvidberg, N E Larsen, et al.
Calcified Tissue International|January 1, 1981
Normalization of bone mineral content to height, weight, and lean body mass: implications for clinical useM S Christensen, C Christiansen, J Naestoft, et al.
Contributions to Nephrology|January 1, 1980
Decreased renal function in association with administration of 1,25-dihydroxyvitamin D3 to patients with stable, advanced renal failureC Christiansen, P Røodbro, M S Christensen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 9, 1975
An easy procedure for in vivo estimation of protein binding and correction of elevated serum values induced by venous stasisC Christiansen, J Naestoft, E F Hvidberg, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Plasma levels of perphenazine and its major metabolites during simultaneous treatment with anticholinergic drugsL B Hansen, J Elley, T R Christensen, et al.
Scandinavian Journal of Gastroenterology|January 1, 1980
Zinc depletion in alcoholic liver diseasesS Kiilerich, O Dietrichson, F B Loud, et al.
British Journal of Clinical Pharmacology|October 1, 1976
Clinical pharmacokinetic studies of perphenazineC Eggert Hansen, T Rosted Christensen, J Elley, et al.
Pageof 2